key: cord-0759536-enfxrob3
authors: Tragni, Vincenzo; Preziusi, Francesca; Laera, Luna; Onofrio, Angelo; Todisco, Simona; Volpicella, Mariateresa; De Grassi, Anna; Pierri, Ciro Leonardo
title: A modular molecular framework for quickly estimating the binding affinity of the spike protein of SARS-CoV-2 variants for ACE2, in presence of mutations at the spike receptor binding domain
date: 2021-05-26
journal: bioRxiv
DOI: 10.1101/2021.05.26.445422
sha: 5cca3e5739eb941fab73f0a7293dd714ee29cbe9
doc_id: 759536
cord_uid: enfxrob3

The rapid spread of new SARS-CoV-2 variants needs the development of rapid tools for predicting the affinity of the mutated proteins responsible for the infection, i.e., the SARS-CoV-2 spike protein, for the human ACE2 receptor, aiming to understand if a variant can be more efficient in invading host cells. Here we show how our computational pipeline, previously used for studying SARS-CoV-2 spike receptor binding domain (RBD)/ACE2 interactions and pre-/post-fusion conformational changes, can be used for predicting binding affinities of the human ACE2 receptor for the spike protein RBD of the characterized infectious variants of concern/interest B.1.1.7-UK (carrying the mutations N501Y, S494P, E484K at the RBD), P.1-Japan/Brazil (RBD mutations: K417N/T, E484K, N501Y), B.1.351-South Africa (RBD mutations: K417N, E484K, N501Y), B.1.427/B.1.429-California (RBD mutations: L452R), the B.1.141 variant (RBD mutations: N439K), and the recent B.1.617.1-India (RBD mutations: L452R; E484Q) and the B.1.620 (RBD mutations: S477N; E484K). Furthermore, we searched for ACE2 structurally related proteins that might be involved in interactions with the SARS-CoV-2 spike protein, in those tissues showing low ACE2 expression, revealing two new proteins, THOP1 and NLN, deserving to be investigated for their possible inclusion in the group of host-cell entry factors responsible for host-cell SARS-CoV-2 invasion and immunity response.

The spread of the new SARS-CoV-2 variants makes necessary the development of new tools able to predict binding affinities of the SARS-CoV-2 spike protein, with the human dipeptidyl carboxydipeptidase angiotensin converting enzyme II (ACE2) receptor [1] [2] [3] . This knowledge might be crucial for evaluating the increased affinity of the spike protein of the new variants of concern (VoC) for the human ACE2 receptor. Indeed, a greater spike/ACE2 affinity may result in a loss of efficiency of vaccines based on a specific spike elder sequence, i.e., the hCoV.19Wuhan.WIV04.2019 [4, 5] . In addition, the obtained information concerning more dangerous (in terms of binding affinity) VoC may help in planning future antibodies [1, 6] and/or rounds of vaccination by using new vaccines based on a cocktail of the newly identified spike sequences (in the form of mRNA [4, 5] or proteins/subdomains [7] [8] [9] ) showing high affinities for the human host-cell receptors.

In this research context our laboratory provided a modular molecular framework for investigating the molecular mechanism that allows SARS-CoV-2 entry in human host cells through SARS-CoV-2 spike receptor binding domain (RBD)/ACE2 interactions [1, 2] .

However, the crystallized structure of RBD/ACE2 protein complex from 6vw1.pdb, used in our previous work [1] , as the only one available at the time (March 2020), consisted of a chimeric SARS-CoV-2 spike RBD [10] and showed 22 missense mutations and a deletion of 3 amino acids at the RBD, with respect to the amino acid sequence of Wuhan SARS-CoV-2 spike protein (as reported in the YP_009724390.1 sequence, namely the hCoV.19Wuhan.WIV04.2019 sequence, https://www.gisaid.org/hcov19-variants/). Thus, we re-estimated the binding interactions between the human ACE2 receptor and SARS-CoV-2 spike RBD, both reported in the new available crystallized structure of the Wuhan SARS-CoV-2 spike protein/ACE2 (6m0j.pdb) protein complex [11] .

It is known that mutations occurring at the RBD are the most dangerous due to their ability in increasing binding affinity for ACE2, favoring virus entry into human host-cells and antibody escape [12] [13] [14] [15] . Thus, aiming to investigate the effect of amino acid replacement . Notably, all the cited VoC genomes have been sequenced in the last year and are responsible for the current pandemics situation [15] [16] [17] [18] [19] [20] [21] .

Finally, given the low expression of ACE2 observed in some tissues highly exposed to SARS-CoV-2, and the acquired knowledge about a set of possible human host-cell entry factors [22] [23] [24] [25] , we used our computational pipeline for predicting ACE2 structurally related receptors, aiming to identify other putative SARS-CoV-2 entry sites in human host cells, based on a folding recognition approach, more than on sequence/functional comparative analysis.

Starting from the atomic coordinates of the SARS-CoV-2 spike RBD protein domain extracted from 6m0j.pdb (according to the YP_009724390.1 sequence), we built the 3D comparative models of the investigated RBD mutants with specific reference to the single mutants N501Y, E484K/Q, N439K, K417N/T, L452R, S477N, S494P, the double mutants L452R-E484Q; and S477N-E484K, and the triple mutants N501Y-E484K-K417N; N501Y-E484K-S494P, N501Y-E484K-K417T by using the mutagenesis tool implemented in SwissPDBViewer [26] .

In order to obtain a pose of the 3D protein complex of SARS-CoV-2 spike RBD mutants interacting with ACE2, the built 3D comparative models of the mutants were superimposed to the 3D protein complex consisting of the Wuhan SARS-CoV-2 spike RBD interacting with ACE2, available under the 6m0j.pdb protein data bank (PDB) entry.

All the generated 3D all-atom models were energetically minimized using the Yasara Minimization server and residues packing was checked and repaired, where necessary, according to the FOLDX repair function [27] . PyMol [28] (https://www.pymol.org) was then used for examining (by manual inspection) the obtained 3D structure models, and for checking the correct packing of local secondary structures.

Crystal structure sampling of possible ACE2 structural related alternative receptors via folding recognition and multiple sequence alignments (MSA) ACE2 structure related proteins were sampled by using the folding recognition methods implemented in pGenThreader [29] and I-Tasser [30] . With this aim, the amino acid sequence of ACE2 (NP_001358344.1) was used as query sequence for running pGenThreader (http://bioinf.cs.ucl.ac.uk/psipred/) and I-Tasser

(https://zhanglab.ccmb.med.umich.edu/I-TASSER/) to screen the Protein Data Bank (PDB), searching for ACE2 structurally related crystallized proteins [1, [29] [30] [31] [32] [33] [34] [35] .

The crystallized structures of the proteins sampled by pGenThreader and I-Tasser analysis were structurally aligned with the 3D coordinates of ACE2 available under the PDB_ID 6m0j.pdb. For obtaining the structural alignment we used the "super" command available in Pymol [28] , which is able to structurally align also proteins with a lower percentage of identical residues, due to its ability in providing a sequence-independent structure-based pairwise alignment [1, 31, 33, 34] .

The sequences of the investigated crystallized ACE2 structurally related proteins were aligned using ClustaW [36] and optimized by visual inspection based on the structural alignment obtained by PyMOL [28] .

In order to obtain the most likely 3D protein complexes of SARS-CoV-2 spike RBD The variation in the number of interactions (H-bonds, ionic and aromatic interactions) at the SARS-CoV-2 spike RBD/ACE2 interface in presence of the investigated amino acid replacements have been calculated by using the PIC webserver [37] and verified by manual inspection by using PyMOL.

The 3D coordinates of the Wuhan SARS-CoV-2 spike RBD crystallized in complex with the human ACE2 receptor available under the PDB_ID 6m0j.pdb were used to estimate the binding affinity of the SARS-CoV-2 spike RBD for the human ACE2 by using the FoldX AnalyseComplex assay [38] . The calculated binding affinity of the two protein domains within the crystallized 6m0j.pdb was used as a reference value for the following comparative analyses [1] .

Indeed, the FoldX AnalyseComplex assay was performed to determine the interaction energy between the investigated minimized protein complexes consisting of the SARS- Furthermore, the FoldX AnalyseComplex assay was used for determining the binding affinity between SARS-CoV-2 spike RBD and the ACE2 structurally related receptors ACE, THOP1, and NLN, identified through pGenTHREADER and/or ITASSER analyses.

The way the FoldX AnalyseComplex operates is by unfolding the selected targets and determining the stability of the remaining molecules and then subtracting the sum of the individual energies from global energy [1] . More negative energies indicate a better binding, whereas positive energies indicate no binding [38, 39] .

The GTEx portal [40] was screened to assess the gene expression levels of ACE2 [24, 25] . More in detail, the investigated L452R and E484Q amino acid replacements cause a local re-arrangement that perturbs the small beta-sheet in the "hull" region of the boat-shaped RBM (residues 450-455, Fig. 2 ), whereas N501Y, K417N, E484K and N439K cause a conformational change in an alpha-helix close to N501 and N439 in the "stern" region (residues 436-449 and 497-503). Although S494P, approximately located in the center of the "boat-hull" region (residues 491-496), and S477N, located on the tip of the "boat-bow" region (residues 468-490) do not produce a viewable local conformational change, it is well known that the replacement of a serine may confer a different flexibility to the local secondary structure elements hosting the investigated mutation, due to the different abilities of Ser/Pro/Asn/Thr residues in producing kink/hinge movements [44, 45] . The perturbation of the local secondary structure of structural elements hosting the cited amino acid replacements also triggers the formation of new H-bonds, ionic and aromatic interactions and local conformational changes at the protein-protein interface along interactions with ACE2 ( Fig. 3, Fig. 4 , Tab. 1, Supp. Tab. 1). The four proteins share a very similar overall structure (Fig. 5) . Indeed, the RMSD of the atomic coordinates of the available THOP1 and NLN crystallized structures and the investigated ACE2 structure ranges between 3.9 and 4.5 Å (Tab. 2, Fig. 5 ). 

At the protein-protein interface it is possible to see that ACE shows two alpha-helices, similarly oriented to the two alpha-helices that represent in ACE2 the main surface of interaction with SARS-CoV-2 spike RBD. THOP1 and NLN show the same alpha-helices in close contact with the SARS-CoV-2 spike RBD and an extra helix parallel to the previous two, forming other interactions with the RBD of the SARS-CoV-2 spike RBD (Fig. 6 ). Although the investigated proteins share a low percentage of identical residues, local secondary structures crucial for interactions with the SARS-CoV-2 spike RBD, consisting of the investigated receptor residues located within 4 Å from the RBD are very similar (Fig. 7) .

The ACE protein region in contact with the RBD is the most similar to the corresponding counterpart in ACE2 (Fig. 7) . The four proteins share one longer helix similarly oriented (residues L29-Q50, ACE2 sequence numbering; and residues L65-Q86, THOP1 sequence numbering) and one superimposable beta-sheet different in length (residues T347-L359, ACE2 sequence numbering, and residues A426-L459, THOP1 sequence numbering).

THOP1 and NLN show an extra helix consisting of their N-terminal region (residues L24-T64, THOP1 sequence numbering) and show a beta-sheet in place of the helix located close to the "stern" portion of the boat-shaped RBD head (residues T324-L333, ACE2 sequence numbering, and residues E406-L415, THOP1 sequence numbering). A last region with a relative different orientation in the space consists of the THOP1 bent helix (residues M112-K128, THOP1 sequence numbering) corresponding to the ACE2 bent helix (residues L73-Q89, ACE2 sequence numbering) (Fig. 7) . While ACE shows an interaction energy with RBD lower than the ones observed in presence of ACE2, the calculated interaction energies between the SARS-CoV-spike RBD and THOP1 or NLN appear to be stronger than those calculated for ACE2 (Table 3) . 

GTEx database was screened for estimating the expression levels of ACE2, ACE, THOP1

and NLN together with other SARS-CoV-2 host-cell entry factors in all the tissues available on GTEx. From this analysis, THOP1 resulted more expressed than ACE2 in all the screened tissues (with the exception of kidney cortex, heart left ventricle, adipose visceral, small intestine, showing THOP1/ACE2 similar expression levels) and, most importantly, it is highly expressed in the lung, in the colon, in the esophagus mucosa and in all the brain compartments, in which ACE2 appears poorly expressed (Fig. 8) . The expression of NLN or ACE is comparable to or slightly higher than ACE2 expression in all the investigated tissues with the exception of heart, adipose tissue, intestine and testis. spike protein, whose interactions with ACE2 receptor triggers pre-/post-fusion conformational changes causing the virus entry into the human cells [1, 9] . The spike domain responsible for direct interactions with the human ACE2 receptor is the RBD [1, 3, 41, [51] [52] [53] . Thus, great attention is dedicated to mutations occurring at the SARS-CoV-2 spike RBD, because they can cause an increase in the binding affinity of the spike protein for the human ACE2 receptor, which may reflect an increased transmissibility or a new acquired antibody escape ability [1, [12] [13] [14] [15] 54] .

Previously [1] , we have determined the interaction energies between the SARS-CoV-2 spike RBD and the human ACE2 receptor available under the PDB_ID 6vw1.pdb [1, 10] . However, the crystallized structure of 6vw1.pdb consisted of a chimeric SARS-CoV-2 spike RBD interacting with ACE2 [10] . The chimeric RBD from 6vw1.pdb showed 22 missense mutations and the deletion of three residues at the RBD with respect to the amino acid sequence of SARS-CoV-2 spike RBD according to the Wuhan reference sequence available under the refseq accession number YP_009724390.1. Less than one year ago coordinates of the SARS-CoV-2 spike RBD (according to YP_009724390.1) crystallized in complex with the human ACE2 receptor were made available under the PDB_ID 6moj.pdb [11] . Thus, we used the 3D coordinates of 6m0j for re-estimating the interaction energies at the SARS-CoV-2 spike RBD/ACE2 protein-protein interface and we modelled RBD mutants on the 6m0j.pdb protein template and quantified the affinity of the known RBD mutants for the human ACE2 receptor. More in detail we studied the impact of the mutations responsible for binding interactions in the short/medium-range (3.8-9.5 Å) interactions [55] .

In terms of binding affinity and interaction energies, it appears that the single amino acid replacements N439K (B1.141 VoC) and E484K (detected in several VoC) cause the most dramatic increase in interaction energies. In addition, the triple mutant N501Y_E484K_K417T detected in the B.1.351-SA VoC [14, 21] shows an increase of about 4 % in binding affinity that might reflect the greater ability shown by this VoC in escaping antibodies produced as a consequence of SARS-CoV-2 Wuhan-sequence based vaccination [14] . Also, the B.1.1.7_UK S494P_N501Y_E484K VoC shows an important variation in the interactions at the ACE2/RBD interface and a decrease in the calculated interaction energies. Notably, this VoC shows the replacement of S494 with a proline residue. P, S, and G play a hinge role in local secondary structures especially when other P, S or G are near in the sequence [45, 56] . The replacement of a serine with a proline may confer less flexibility to the local secondary structure and thus it is retained this mutation limits RBD local flexibility causing a decrease in the number of short/medium-range interactions [55] at the ACE2/RBD interface. It can be argued that the limited flexibility introduced by the S494P amino acid replacement decreases the affinity for ACE2 and makes sensitive this VoC to antibodies produced by vaccination [21] . It is retained that mutations like D614G and P681H, being located in the N-terminal portion of the spike pre-fusion conformation, despite of their relatively great distance from the SARS-CoV-2 spike RBD/ACE2 protein-protein interface, can confer a different flexibility (increased for the D614G mutant and decreased for the P681H mutant) to the entire spike protein, before cleavage events determining the post-fusion conformation, following the spike N-terminal loss [1] . Indeed, it was observed that a successful interaction of the spike protein with the ACE2 receptor is supported by the high flexibility of the SARS-CoV-2 spike protein in the pre-fusion conformation, while scanning host-cell surface [2, 3] .

Our conclusions about changes in binding energies and number of interactions for the investigated VoC are coherent with the expected effects about spike RBD/ACE2 interactions and antibody escape reported for the described VoC [12] [13] [14] [15] [18] [19] [20] [21] .

While several studies about in vitro ACE2/spike binding assays are becoming available, an Our in silico molecular framework allows to obtain a quick estimation of ACE2/RBD interaction energies that can provide a reliable idea of the ACE2/RBD variant affinity. The same molecular framework can be easily adapted, also based on the future available solved structures, for estimating ACE2/spike interactions by using the entire spike protein instead of the only RBD, for using various ACE2/spike ratios (i.e., 2 spike proteins with 6 ACE2 proteins, as previously described [1] ) and to relax the obtained all-atom systems by using molecular dynamics [61, 62] .

Among the investigated VoC-RBDs, the triple RBD mutant of the B. [24] shown by resistant individuals, starting from putative ACE2 variants [66, 67] .

In the end, we wondered about the possible existence of ACE2 structurally related receptors that might interact with SARS-CoV-2 spike RBD in those tissues showing ACE2 poorly expressed [24, 25] . Our fold-recognition based analysis revealed that beyond the expected ACE, THOP1 and NLN appear structurally related to ACE2. ACE, THOP1 and NLN share the "oligopeptidase/receptor" activity with ACE2, and show at least one isoform localized at the plasma membrane [68, 69] . While ACE appears to form a weaker protein complex with the SARS-CoV-2 spike RBD, in our interaction analyses, the interaction energies calculated at the protein-protein interface of the SARS-CoV-2 spike RBD/THOP1 or SARS-CoV-2 spike RBD/NLN show binding energies higher than those calculated for the SARS-CoV-2 spike RBD/ACE2 protein complex, maybe due to a supplementary alpha-helix located at the interface with the SARS-CoV-2 spike RBD in the obtained 3D protein complexes. NLN and THOP1 participate to the cleavage of cytosolic peptides and share the 80% of identical residues [69] .

While the expression of NLN or ACE is comparable to or slightly higher than ACE2 expression in all the investigated tissues, it is possible to see that THOP1 is highly more expressed than ACE2 in most of the screened tissues and, most importantly, it is highly expressed in the lung, in the colon, in the esophagus mucosa and in all the brain compartments.

Although THOP1 and ACE2 show a low percentage of identical residues (< 30%), their related biochemical function and high structural similarity (overall RMSD < 4.5 Å) make THOP1 a suggestive/alternative candidate receptor for the SARS-CoV-2 spike protein. In addition, in our GTEx analyses the high expression of THOP1 appears to correlate with high expression levels of the Furin protease, which may participate to spike cleavage allowing pre-/post-fusion conformational changes crucial for host-cell penetration [24, 70] , above all in those tissues showing a low ACE2 expression, i.e., in the lung, in the esophagus mucosa or in the brain. Notably, THOP1 expression was observed upregulated in COVID-19 infected patients and in particular in the effector CD8 T-cells of COVID-19 patients at the beginning of the infection [71] . Furthermore, THOP1 appears to play a crucial role in the regulation of MHC I cell-surface expression [72] [73] [74] . Due to the shown high expression of THOP1 in several brain compartments and in the effector CD8 T-cells of COVID-19 patients [71] , it raises the question about a possible relationship between different SARS-CoV-2 immune responses [75, 76] , neurological disorders observed in long covid patients, and THOP1 involvement in MHC-class I regulation in COVID-19 patients [77] [78] [79] .

Authors would like to thank the Italian Association for Mitochondrial Research (www.mitoairm.it) for having provided part of the computational resources used for the presented analyses.

All data generated or analysed data here presented study are included in this published article and its supplementary information files. 3D atomic coordinate of the generated PDF files are available upon request.

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Code availability All the necessary information and protein accession numbers are provided along the manuscript 

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Recombinant protein vaccines, a proven approach against coronavirus pandemics

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Front Immunol

Structural basis of receptor recognition by SARS-CoV-2

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

SARS-CoV-2 immune evasion by variant B.1.427/B

Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities

CorGAT: a tool for the functional annotation of SARS-CoV-2 genomes

Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

The protein expression profile of ACE2 in human tissues

Single-Cell RNA Expression Map of Human Coronavirus Entry Factors

ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with

Cardiovascular Risk Factors

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8

PyDeT, a PyMOL plug-in for visualizing geometric concepts around proteins

pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination

The I-TASSER suite: Protein structure and function prediction

FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function

Targeting Penicillium expansum GMC Oxidoreductase with High Affinity Small Molecules for Reducing Patulin Production

Molecular modeling of antibodies for the treatment of TNFα-related immunological diseases

Prediction of high-and lowaffinity quinol-analogue-binding sites in the aa3and bo3 terminal oxidases from Bacillus subtilis and Escherichia coli

Computational approaches for protein function prediction: A combined strategy from multiple sequence alignment to molecular docking-based virtual screening

Bioinformatics in protein analysis

PIC: Protein Interactions Calculator

The FoldX web server: An online force field

A graphical interface for the FoldX forcefield

The Genotype-Tissue Expression (GTEx) project

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science (80-) 7269:eabb7269

The SARS-CoV-2 Vaccine Pipeline: an Overview

Structure and function of mitochondrial carriers -role of the transmembrane helix P and G residues in the gating and transport mechanism

Serine and threonine residues bend alpha-helices in the chi(1) = g(-) conformation

Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design

Crystal Structure of Human Thimet Oligopeptidase Provides Insight into Substrate Recognition, Regulation, and Localization

Structure of neurolysin reveals a deep channel that limits substrate access

Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity

Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion

Structural basis for human coronavirus attachment to sialic acid receptors

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Distance-dependent hydrophobichydrophobic contacts in protein folding simulations

Ser and Thr residues modulate the conformation of pro-kinked transmembrane alpha-helices

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Mutation N501Y in RBD of Spike Protein Strengthens the Inter-action between COVID-19 and its Receptor ACE2

Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern. Front Immunol

Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay

Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV

Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals

Covid-19: Do many people have pre-existing immunity?

Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells

Mechanism of Peptide Binding and Cleavage by the Human Mitochondrial Peptidase Neurolysin

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

Plasma proteomics reveals tissuespecific cell death and mediators of cell-cell interactions in severe COVID-19 patients

Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase)

Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol

Thimet oligopeptidase (EC 3.4.24.15) key functions suggested by knockout mice phenotype characterization

The immune response to SARS-CoV-2 and COVID-19 immunopathology -Current perspectives

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol

Sleep deprivation changes thimet oligopeptidase (THOP1) expression and activity in rat brain

Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce "Brain Fog" and results in behavioral changes that favor viral survival

Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Authors would like to thank the Italian Association for Mitochondrial Research (www.mitoairm.it) for hosting the webpage (https://www.mitoairm.it/covid19affinities) that will allow interested researchers to run the presented pipeline for their targets. Authors would also like to thank for the IT resources made available by ReCaS